Agrippal (influenza vaccine (surface antigen inactivated)): Reviews and patient testimonials


/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Back Back to the list of medications

Medication indications

Agrippal Influenza vaccine (surface antigen, inactivated)

Prophylaxis of influenza, especially in those who run an increased risk of associated complications.

Agrippal is indicated in adults and children from 6 months of age.

The use of Agrippal should be based on official recommendations.


Molecule: influenza vaccine (surface antigen, inactivated)

Patients' opinions on Agrippal

In brief

General satisfaction level: Be the first to evaluate

Treatment's effectiveness: Be the first to evaluate

Ease of use: Be the first to evaluate

Adherence to prescription: Be the first to evaluate

Detected side effects: Be the first to evaluate

Improvement in the quality of life: Be the first to evaluate

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.